Simon M Ametamey
Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors
Haider A, Pacher P, Herde A, Spinelli F, Ahmed H, Atz K, Keller C, Weber M, Schibli R, Mu L, Grether U, Knuesel I, Bartelmus C, Gobbi L, Kretz J, Ullmer C, Brink A, Honer M, Woltering T, Muri D, Iding H, Bürkler M, Binder M, Ametamey S. Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors. J Med Chem 2020; 63:10287-10306.
Sep 1, 2020Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors
Sep 1, 2020J Med Chem 2020; 63:10287-10306
Haider Ahmed, Pacher Pal, Herde Adrienne Müller, Spinelli Francesco, Ahmed Hazem, Atz Kenneth, Keller Claudia, Weber Markus, Schibli Roger, Mu Linjing, Grether Uwe, Knuesel Irene, Bartelmus Christian, Gobbi Luca, Kretz Julian, Ullmer Christoph, Brink Andreas, Honer Michael, Woltering Thomas J, Muri Dieter, Iding Hans, Bürkler Markus, Binder Martin, Ametamey Simon M
Radiation dosimetry of F-AzaFol: A first in-human use of a folate receptor PET tracer
Gnesin S, Prior J, Treyer V, Kaufmann P, Ametamey S, Schibli R, Müller C, Choschzick M, Früh M, Siano M, Meisel A, Burger I, Müller J, Schaefer N. Radiation dosimetry of F-AzaFol: A first in-human use of a folate receptor PET tracer. EJNMMI Res 2020; 10:32.
Apr 8, 2020Radiation dosimetry of F-AzaFol: A first in-human use of a folate receptor PET tracer
Apr 8, 2020EJNMMI Res 2020; 10:32
Gnesin Silvano, Prior John O, Treyer Valerie, Kaufmann Philipp A, Ametamey Simon M, Schibli Roger, Müller Cristina, Choschzick Matthias, Früh Martin, Siano Marco, Meisel Alexander, Burger Irene A, Müller Joachim, Schaefer Niklaus
Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients
Müller Herde A, Schibli R, Weber M, Ametamey S. Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients. Eur J Nucl Med Mol Imaging 2018
Oct 5, 2018Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients
Oct 5, 2018Eur J Nucl Med Mol Imaging 2018
Müller Herde Adrienne, Schibli Roger, Weber Markus, Ametamey Simon M
Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2
Slavik R, Müller Herde A, Haider A, Krämer S, Weber M, Schibli R, Ametamey S, Mu L. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2. J Neurochem 2016; 138:874-86.
Aug 2, 2016Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2
Aug 2, 2016J Neurochem 2016; 138:874-86
Slavik Roger, Müller Herde Adrienne, Haider Ahmed, Krämer Stefanie D, Weber Markus, Schibli Roger, Ametamey Simon M, Mu Linjing
Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor
Mu L, Slavik R, Müller A, Popaj K, Cermak S, Weber M, Schibli R, Krämer S, Ametamey S. Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor. Pharmaceuticals (Basel) 2014; 7:339-52.
Mar 6, 2014Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor
Mar 6, 2014Pharmaceuticals (Basel) 2014; 7:339-52
Mu Linjing, Slavik Roger, Müller Adrienne, Popaj Kasim, Cermak Stjepko, Weber Markus, Schibli Roger, Krämer Stefanie D, Ametamey Simon M
Development and evaluation of novel PET tracers for imaging cannabinoid receptor type 2 in brain
Slavik R, Bieri D, Cermak S, Müller A, Krämer S, Weber M, Schibli R, Ametamey S, Mu L. Development and evaluation of novel PET tracers for imaging cannabinoid receptor type 2 in brain. Chimia (Aarau) 2014; 68:208-10.
Jan 1, 2014Development and evaluation of novel PET tracers for imaging cannabinoid receptor type 2 in brain
Jan 1, 2014Chimia (Aarau) 2014; 68:208-10
Slavik Roger, Bieri Daniel, Cermak Stjepko, Müller Adrienne, Krämer Stefanie D, Weber Markus, Schibli Roger, Ametamey Simon M, Mu Linjing
Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor
Mu L, Krämer S, Schibli R, Weber M, Cermak S, Müller A, Drandarov K, Slavik R, Bieri D, Ametamey S. Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor. J Neurochem 2013; 126:616-24.
Jul 19, 2013Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor
Jul 19, 2013J Neurochem 2013; 126:616-24
Mu Linjing, Krämer Stefanie D, Schibli Roger, Weber Markus, Cermak Stjepko, Müller Adrienne, Drandarov Konstantin, Slavik Roger, Bieri Daniel, Ametamey Simon M